Sponsor Pipeline

Nasus Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
Active Trials by Phase
Phase 2/3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07045701 FMXIN002 in Patients at Risk of Anaphylaxis Anaphylaxis Food Enrolling by Invitation
Phase 1/2
NCT07228325 Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis Anaphylaxis Enrolling by Invitation
Get alerts when Nasus Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free